Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.Biochemistry|March 19, 2003
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAbG B McGaughey, M Citron, R C Danzeisen, et al.Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.Journal of Medicinal Chemistry|October 1, 1988
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.Journal of Medicinal Chemistry|November 16, 2001
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.The Journal of Biological Chemistry|March 28, 1998
Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogsS D Lewis, B J Lucas, S F Brady, et al.Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Identification of an orally active, nonpeptidyl oxytocin antagonistD J Pettibone, B V Clineschmidt, M T Kishel, et al.Pageof 5